Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
3.830
-0.090 (-2.30%)
At close: Nov 7, 2025, 4:00 PM EST
3.770
-0.060 (-1.57%)
After-hours: Nov 7, 2025, 6:01 PM EST
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.05 billion as of November 7, 2025. Its market cap has increased by 159.85% in one year.
Market Cap
1.05B
Enterprise Value
820.85M
1-Year Change
159.85%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.05B, an increase of 51.95%. That is a compound annual growth rate of 8.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.05B | 195.90% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.15% |
| Sep 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |